2022. Dose Optimisation in Early Oncology Trials: Moving Beyond the Maximum Tolerated Dose. Translational Medicine & Therapeutics Journal. 1, 1 (Feb. 2022), 10–18. DOI:https://doi.org/10.5281/zenodo.22648819.